Kyntra Bio, Inc. (KYNB)
8.02
+0.02
(+0.25%)
USD |
NASDAQ |
Aug 28, 16:00
7.975
-0.04
(-0.56%)
After-Hours: 20:00
Kyntra Bio Price : 8.02 for Aug. 28, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | 7.99 | 8.02 | 7.80 | 8.02 | 15784.00 |
| Aug 27, 2026 | 8.01 | 8.12 | 7.92 | 8.00 | 5867.00 |
| Aug 26, 2026 | 8.11 | 8.15 | 7.95 | 8.105 | 7394.00 |
| Aug 25, 2026 | 8.00 | 8.12 | 7.75 | 8.10 | 45181.00 |
| Aug 24, 2026 | 7.67 | 7.98 | 7.65 | 7.98 | 25651.00 |
| Aug 21, 2026 | 7.35 | 7.60 | 7.30 | 7.52 | 40009.00 |
| Aug 20, 2026 | 7.09 | 7.39 | 6.863 | 7.32 | 23976.00 |
| Aug 19, 2026 | 7.175 | 7.24 | 6.945 | 7.15 | 18770.00 |
| Aug 18, 2026 | 6.81 | 7.253 | 6.81 | 7.01 | 13735.00 |
| Aug 17, 2026 | 6.94 | 7.158 | 6.81 | 6.81 | 25777.00 |
| Aug 14, 2026 | 7.025 | 7.407 | 6.951 | 7.05 | 17735.00 |
| Aug 13, 2026 | 7.03 | 7.15 | 7.03 | 7.04 | 3784.00 |
| Aug 12, 2026 | 7.14 | 7.231 | 7.045 | 7.10 | 4228.00 |
| Aug 11, 2026 | 6.91 | 7.20 | 6.91 | 7.07 | 13018.00 |
| Aug 10, 2026 | 7.29 | 7.333 | 6.97 | 6.97 | 3516.00 |
| Aug 07, 2026 | 6.97 | 7.30 | 6.97 | 7.27 | 5203.00 |
| Aug 06, 2026 | 6.93 | 7.110 | 6.93 | 6.980 | 1520.00 |
| Aug 05, 2026 | 6.90 | 7.068 | 6.75 | 6.99 | 7317.00 |
| Aug 04, 2026 | 6.99 | 7.00 | 6.885 | 6.92 | 8799.00 |
| Aug 03, 2026 | 6.88 | 6.977 | 6.750 | 6.76 | 4985.00 |
| Jul 31, 2026 | 6.83 | 6.889 | 6.66 | 6.73 | 4646.00 |
| Jul 30, 2026 | 6.77 | 6.905 | 6.709 | 6.79 | 5873.00 |
| Jul 29, 2026 | 6.945 | 6.95 | 6.78 | 6.78 | 6586.00 |
| Jul 28, 2026 | 7.18 | 7.18 | 6.89 | 6.975 | 8922.00 |
| Jul 27, 2026 | 7.04 | 7.12 | 7.010 | 7.05 | 4657.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vericel Corp. | 40.95 |
| Capricor Therapeutics, Inc. | 9.59 |
| ARS Pharmaceuticals, Inc. | 5.89 |
| ACADIA Pharmaceuticals, Inc. | 29.11 |
| Alnylam Pharmaceuticals, Inc. | 237.10 |
Price Related Metrics
| PE Ratio | 0.2483 |
| PS Ratio | 7.029 |
| Earnings Yield | 402.8% |
| Market Cap | 32.47M |
| Normalized PE Ratio | 0.2397 |